Mecklenburg-Western Pomerania's Minister of Science, Bettina Martin, announced today (July 31, 2023) in Greifswald 15 million euros of additional state funding for the construction of the Helmholtz Institute for One...
The constant rise in antimicrobial resistance (AMR) has a major impact on global public health, urgently requiring novel strategies to prevent and treat bacterial infections. The development of effective vaccines...
The Else Kröner-Fresenius Foundation's ForTra gGmbH for Research Transfer—the largest medicine-funding foundation in Germany—supports the legally compliant production of new drug candidates for direct use in...
In his doctoral thesis at the Helmholtz Institute for RNA-based Infection Research (HIRI), Chunlei Jiao has paved the way for the development of the CRISPR-based RNA detection and recording platforms known as LEOPARD...
With numerous supporters, cooperation partners and companions, the Helmholtz Institute for RNA-based Infection Research (HIRI) Würzburg celebrated its groundbreaking ceremony today, July 6. The institute, a site of the...
From 1 July 2023, Professor Josef Penninger takes over the Scientific Management of the Helmholtz Centre for Infection Research (HZI). Penninger is internationally renowned for his outstanding contributions to genetic...
At first glance, nature conservation and antibiotics have little in common. However, a new collaboration project between the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) and the Naturlandstiftung Saar...
Yesterday, the official go-ahead was given for Lower Saxony's new lighthouse project. At the first public event of the Institute for Biomedical Translation (IBT) Lower Saxony, a top-class jury selected the pilot project...
Some bacterial pathogens form so-called biofilms during infection processes to protect themselves from drugs or cells of the human immune system. Every year, more than 500,000 people die from infections associated with...